Towards personalized PARP therapy: XRT-induced Rad51 predicts re- sponse to ABT-888 in ovarian cancer

Authors :: Monjri Shah
Zachary C. Dobbin
A. Katre
Charles N. Landen
Somaira Nowsheen
Ronald D. Alvarez
Eddy S. Yang
Britt K. Erickson
Panagiotis A. Konstantinopoulos
Source :: Gynecologic Oncology. 130:e35
Publication Year :: 2013
Publisher :: Elsevier BV, 2013.

Subjects :: Oncology
medicine.medical_specialty
business.industry
Internal medicine
Poly ADP ribose polymerase
medicine
RAD51
Obstetrics and Gynecology
business
Ovarian cancer
medicine.disease

Full Text Access

Tools